Class 4 Medicines Defect Information: OxyContin 20 mg prolonged release tablets,

Napp Pharmaceuticals Limited has identified an error relating to the Braille printed on the cartons. The Braille message on the Oxycontin 20mg prolonged release tablets incorrectly states strength as 15mg.

Further information and details of the affected products can be found on the MHRA website.